Does CARBIDOPA\LEVODOPA Cause Salivary hypersecretion? 248 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 248 reports of Salivary hypersecretion have been filed in association with CARBIDOPA\LEVODOPA. This represents 0.4% of all adverse event reports for CARBIDOPA\LEVODOPA.
248
Reports of Salivary hypersecretion with CARBIDOPA\LEVODOPA
0.4%
of all CARBIDOPA\LEVODOPA reports
30
Deaths
127
Hospitalizations
How Dangerous Is Salivary hypersecretion From CARBIDOPA\LEVODOPA?
Of the 248 reports, 30 (12.1%) resulted in death, 127 (51.2%) required hospitalization, and 9 (3.6%) were considered life-threatening.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARBIDOPA\LEVODOPA. However, 248 reports have been filed with the FAERS database.
What Other Side Effects Does CARBIDOPA\LEVODOPA Cause?
Fall (7,132)
Death (5,403)
Dyskinesia (5,368)
Tremor (3,689)
General physical health deterioration (3,636)
On and off phenomenon (3,509)
Hallucination (3,367)
Drug ineffective (3,205)
Parkinson's disease (3,140)
Device dislocation (2,937)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
SERTRALINE (163)
Which CARBIDOPA\LEVODOPA Alternatives Have Lower Salivary hypersecretion Risk?
CARBIDOPA\LEVODOPA vs CARBIMAZOLE
CARBIDOPA\LEVODOPA vs CARBOCYSTEINE
CARBIDOPA\LEVODOPA vs CARBOMER
CARBIDOPA\LEVODOPA vs CARBON DIOXIDE
CARBIDOPA\LEVODOPA vs CARBON MONOXIDE